📰 Alfasigma News
Alfasigma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alfasigma. Real-time updates on events, politics, business and more.
January 2, 2024
Galapagos NV (GLPG), a bio-pharmaceutical company, Tuesday said it entered into a deal to sell its Jyseleca business to Italian pharma company Alfasigma. As per the terms of the agreement, Michele Manto the Chief Commercial Officer of the company has resigned and will be joining Alfasigma in the same capacity.
November 8, 2023
BOLOGNA, Italy, November 08, 2023--Alfasigma S.p.A. ("Alfasigma") announced today that it has, through its wholly owned subsidiary Interstellar Acquisition Inc. ("Interstellar"), successfully completed its tender offer to purchase all outstanding shares of common stock of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) ("Intercept"), at a price of USD 19.00 per share, net to the seller thereof in cash, without interest, less any applicable withholding of taxes.
October 26, 2023
BOLOGNA, Italy, October 26, 2023--Alfasigma S.p.A. ("Alfasigma") today announced that the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") with respect to Alfasigma’s proposed acquisition of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) ("Intercept") expired at 11:59 p.m. on October 25, 2023. The expiration of the HSR Act waiting period satisfies one of the conditions to consummate the tender offer. Other...
September 26, 2023
MONSEY, N.Y., Sept. 26, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Intercept...
September 26, 2023
Intercept Pharmaceuticals’ acquisition by Alfasigma comes three months after the FDA again rejected the biotech’s drug as a treatment for the fatty liver disease NASH. But Intercept still has rare liver disease assets, and Italy-based Alfasigma says acquiring the company will help it expand in gastroenterology and hepatology.
May 27, 2022
- - WDHD 2022 is dedicated to raising awareness on colorectal cancer prevention - In Europe more than 519,820 new cases of colorectal cancer (CRC) were ...
May 27, 2022
- WDHD 2022 is dedicated to raising awareness on colorectal cancer prevention - In Europe more than 519,820 new cases of colorectal cancer (CRC) were diagnosed in 2020 - Adenoma detection
September 16, 2021
/PRNewswire/ -- Mit einer Anfangsinvestition von über 17 Millionen Euro für die Entwicklung von 5.600 m2 neuer Labore für pharmazeutische Technologie und...
April 1, 2021
Share this article Share this article v-WIN Foundation and Alfasigma together to fight one of the leading causes of preventable death: venous thrombosis Italy as the hub of an international public awareness project on venous and lymphatic health of the legs to be presented in DUBAI during the EXPO An innovative geo-localization software has being launched to increase knowledge & awareness about the disease BOLOGNA, Italy, April 1, 2021 /PRNewswire/ -- Venous-lymphatic World International Netw...
March 9, 2021
Alfasigma: Jacopo Murzi is the new General Manager of the Italy Business Unit Murzi comes with extensive international experience He will lead the Italian team of Alfasigma bringing together the Pharma Italy and Consumer Health Care divisions BOLOGNA, Italy, March 9, 2021 /PRNewswire/ -- Jacopo Murzi, 49, joins Alfasigma Spa as General Manager of the Italy Business Unit which today includes the Pharma Italy, Consumer Healthcare, Commercial Operations, Market Access and BU Diversified division...